PARKINSON'S DISEASE
- 1 December 1997
- journal article
- Published by Elsevier in Psychiatric Clinics of North America
- Vol. 20 (4) , 769-790
- https://doi.org/10.1016/s0193-953x(05)70344-0
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Sustained-release Madopar HBS® compared with standard Madopar® in the long-term treatment of de novo parkinsonian patientsActa Neurologica Scandinavica, 1996
- Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Comparative study of selegiline plus L‐dopa–carbidopa versus L‐dopa–carbidopa alone in the treatment of parkinson's diseaseAnnals of Neurology, 1995
- Pergolide compared with bromocriptine in Parkinson's disease: A multicenter, crossover, controlled studyMovement Disorders, 1994
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- PergolideDrugs, 1990
- Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical CorrelatesJournal of Geriatric Psychiatry and Neurology, 1988
- Management of Levodopa FailuresClinical Neuropharmacology, 1986
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- DEMENTIA IN PARKINSON'S DISEASEActa Neurologica Scandinavica, 1976